MEDIUM confidence: 100% data completeness, but the composite (51) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $18.3B— | $20.0B+9.2% | $17.5B-12.5% | $15.6B-10.7% | $17.7B+13.0% |
| EPS (dil.) | $8.27— | $9.41+13.8% | $7.07-24.9% | $5.20-26.4% | $5.45+4.8% |
| Free Cash Flow | $6.3B— | $5.9B-5.9% | $1.3B-77.2% | $1.5B+11.0% | $2.6B+73.8% |
| Gross Margin | 67.5% | 68.8%+1.3pp | 62.9%-5.9pp | 58.1%-4.8pp | 57.0%-1.1pp |
| Operating Margin | 48.8% | 50.6%+1.8pp | 41.8%-8.8pp | 34.9%-6.9pp | 34.1%-0.9pp |
| Net Margin | 42.4% | 43.7%+1.3pp | 37.2%-6.5pp | 30.7%-6.5pp | 28.3%-2.4pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net insider -$88.9M over 180 days (0 open-market buys, 32 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Avg target $330 (last qtr, 21 analysts) → $325 (last mo, 14) (-1.7%).
Buy-rated share 45% → 50% over ~3 months (+5pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $1.91 | $2.14 | +12.0% |
| Apr 2026 | $1.36 | $1.68 | +23.5% |
| Jan 2026 | $1.29 | $1.27 | -1.6% |
| Oct 2025 | $1.49 | $1.48 | -0.7% |
| Jul 2025 | $1.36 | $1.41 | +3.7% |
| Apr 2025 | $1.07 | $1.28 | +19.6% |
| Jan 2025 | $1.20 | $1.30 | +8.3% |
| Oct 2024 | $1.38 | $1.47 | +6.5% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 11.3%/yr (revenue basis).
Base free cash flow $1.8B (avg FY2023–FY2025; latest year $2.6B) · equity value $253.2B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 51 for Texas Instruments indicates a neutral outlook, driven by a strong profitability profile, with a score of 56, and a relatively low risk score of 58. However, the stock's value score of 49 is weighed down by its premium valuation, with a P/E of 42.0 and P/B of 14.0. The growth and momentum scores are also moderate, at 47, reflecting a mix of robust revenue growth and weaker recent price action, with a 12-month return of 43.5% but a 3-month decline of 9.6%.